Development of expectations and their influence on treatment response in patients with rheumatoid arthritis

Development of expectations and their influence on treatment response in patients with rheumatoid arthritis - YOSO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017042

Enrollment

150

Registered

2019-03-26

Start date

2018-03-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M05 M06

Interventions

Group 1: At timepoint T0 before change of therapy in patients with rheumatoid arthritis the following questionnaires are assessed: Questionnaire on patient expectations, questionnaire on physician-pat

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: rheumatoid arthritis according to ACR/EULAR classifications criteria, age >18 years, sufficient German language skills

Exclusion criteria

Exclusion criteria: insufficient German language skills, no written informed consent

Design outcomes

Primary

Measure	Time frame
Treatment response at 3 months (change in DAS28)	—

Secondary

Measure	Time frame
Change in heart rate variabiliy at 3 months, change in neuropeptide Y and vasoactive intestinal peptide - concentrations at 3 months	—

Countries

Germany

Contacts

Public ContactJohanna Mucke

Poliklinik und Funktionsbereich für Rheumatologie und Hiller-Forschungszentrum, Universitätsklinikum Düsseldorf

johanna.mucke@med.uni-duesseldorf.de02118117817

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026